Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache-Reference-Cited by-同舟云学术

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

Published:2021-07-05 Issue:2 Volume:43 Page:1273-1280
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Pensato Umberto,Baraldi Carlo,Favoni Valentina,Cainazzo Maria Michela,Torelli Paola,Querzani Pietro,Pascazio Alessia,Mascarella Davide,Matteo Eleonora,Quintana Simone,Asioli Gian Maria,Cortelli Pietro,Pierangeli Giulia,Guerzoni Simona,Cevoli Sabina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-021-05426-5.pdf

Reference39 articles.

1. Natoli JL, Manack A, Dean B et al (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599–609

2. Munksgaard SB, Jensen RH (2014) Medication overuse headache. Headache 54:1251–1257

3. Lanteri-Minet M, Duru G, Mudge M, Cottrell S (2011) Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31:837–850

4. D’Amico D, Leone M, Grazzi L, Bussone G (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis? Neurol Sci 29(Suppl 1):S55–S58

5. Schulman EA, Brahin EJ (2008) Refractory headache: historical perspective, need, and purposes for an operational definition. Headache 48:770–777

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are we closer to achieving precision medicine for migraine treatment? A narrative review;Cephalalgia;2024-09

2. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis;European Journal of Pharmacology;2024-08

3. Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study;Headache: The Journal of Head and Face Pain;2024-07-16

4. Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis;The Journal of Headache and Pain;2024-07-04

5. Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study;Neurological Sciences;2024-05-25